Healthcare and Pharmaceuticals
Merck (NYSE: MRK) revealed positive results from a Phase 2b/3 trial of clesrovimab, a monoclonal antibody for RSV prevention in infants. Key endpoints showed a 60.4% reduction in RSV-associated lower respiratory infections and an 84.2% reduction in hospitalizations. Clesrovimab demonstrated a safety profile comparable to existing treatments, with potential availability by the 2025 RSV season. Read More
Verastem Oncology presented updated Phase 2 RAMP 201 data on avutometinib and defactinib in serous ovarian cancer, showing 31% overall response rate and 61% disease control rate. The company aims for an NDA submission in October 2024. Read More
Avadel Pharmaceuticals (Nasdaq: AVDL) announced FDA approval of LUMRYZ for narcolepsy treatment, the only once-at-bedtime oxybate option, granted Orphan Drug Exclusivity. Read More
RenovaroCube (NASDAQ: RENB)'s research on Oxford Nanopore sequencing demonstrated advances in detecting lung cancer via circulating cell-free DNA. Read More
Nektar Therapeutics (Nasdaq: NKTR) published Phase 1 data of NKTR-255 with CAR-T cell therapy, noting an 89% MRD negative remission and 67% relapse-free survival at 12 months. Read More
Industry Collaborations and Mergers
Vizsla Silver Corp. (NYSE: VZLA) acquired the La Garra-Metates district, issuing 5,555,555 shares and paying US$1,606,500 in taxes. The deal includes a 1% NSR royalty, which can be repurchased for US$750,000. Read More
TuHURA Biosciences completed a merger with Kintara Therapeutics, focusing on Phase 3 trials for cancer immunotherapy. Read More
Sanofi and Orano Med partnered to develop next-gen radioligand cancer treatments, with Sanofi making a €300 million equity investment. Read More
Banking and Financial Sector
Western Alliance Bancorporation (NYSE: WAL) reported Q3 income of $199.8 million, EPS of $1.80, and a 3.61% net interest margin. Deposits increased by $1.8 billion, while loans grew by $916 million. Asset quality remained steady, with non-performing assets at 0.45%. Read More
Metropolitan Bank Holding Corp. (NYSE: MCB) posted strong Q3 results with a 3.62% net interest margin and deposit growth, maintaining strong liquidity at $3.1 billion. Read More
BancFirst (NASDAQ GS: BANF) reported $58.9 million net income and $1.75 EPS for Q3, with an improved net interest margin of 3.78%. Read More
BayCom Corp (NASDAQ: BCML) released Q3 earnings of $6.0 million, noting a slight decrease from the previous year. Non-performing loans improved to 0.51% of total loans. They appointed two new directors to their Board as well. Read More
Bank OZK (Nasdaq: OZK) achieved record Q3 2024 earnings, with a 4.4% increase in net income and a $282.6 million PPNR. Read More
Social Media and Consumer Insights
GoDaddy data shows Gen Z's trust in influencers surging, shifting digital marketing strategies. Read More
Energy and Mining Updates
SLB (NYSE: SLB) finalized an agreement to sell its interests in the Palliser Block, including oil and gas wells and development rights. Closing is anticipated in Q4 2024. Read More
Sphere 3D Corp. (NASDAQ: ANY), enhanced operational capacity with 9.2 Bitcoin mined in September 2024 and launched a 12.5 MW hosting site. Read More
Garrett Motion Inc. (NYSE: GTX) and SinoTruk signed a Letter of Intent for advanced E-powertrain technologies, targeting mass production by 2027. Read More
Vizsla Silver Corp. acquired La Garra-Metates district, agreeing to pay US$1,606,500 in tax and securing 5.6 million shares. Read More
Xenetic Biosciences (NASDAQ: XBIO) reached a Materials Transfer deal with Tokyo Medical University to drive DNase-based oncology platform development. Read More
Comtech (NASDAQ: CMTL) announced a strategy shift to focus on space communications, amending its credit facilities. Read More
